| For: | Li Y, Wu YT, Wu H. Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions. World J Gastroenterol 2025; 31(15): 103512 [PMID: 40309228 DOI: 10.3748/wjg.v31.i15.103512] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i15/103512.htm |
| Number | Citing Articles |
| 1 |
Mengdi Lu, Jing Chen, Hong Zhang, Jia Xu, Xiaojiao Li, Yue Hu, Jingrui Liu, Changlin Ai, Chunhua Shi, Guozhu Geng, Zhenkun Ma, Junqi Niu, Yanhua Ding. A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug. Expert Opinion on Investigational Drugs 2026; : 1 doi: 10.1080/13543784.2026.2619604
|
